Answers are grounded in this paper and cite their sources.
Inflammation is a common immune-related condition in daily life, yet conventional non-steroidal anti-inflammatory drugs often cause adverse reactions and significant risks. Tetrahydropalmatine (THP), a natural isoquinoline alkaloid, has attracted considerable attention for its potent anti-inflammatory activity. However, its poor water solubility and low bioavailability severely limit its clinical application. Therefore, developing an effective hydrophobic drug delivery system to improve the bioavailability of THP is important. Bovine serum albumin nanoparticles (BSA NPs) represent an ideal carrier due to their excellent biocompatibility, high drug-loading capacity, and inherent pH-sensitivity. In this study, THP-loaded BSA nanoparticles (THP-BSA NPs) were successfully prepared using the desolvation method. The THP-BSA NPs had an average hydrodynamic diameter of 279.5 nm and a relatively stable hydrodynamic radius during 14 days of storage at 4 °C. In the loading study with 100 mg BSA, the highest drug loading was 16.05%. THP-BSA NPs displayed sustained-release and pH-responsive properties. In LPS-induced RAW264.7 cells, THP-BSA NPs maintained higher cell viability than THP at the same THP-equivalent concentrations and suppressed NO, ROS, and pro-inflammatory cytokine production. These findings support the potential of BSA NPs as a carrier for sustained THP delivery and provide a basis for further development of anti-inflammatory formulations.
No takes yet. Share an insight, caveat, or question.
Bie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: